Lafora body disease: a case of progressive myoclonic epilepsy
- PMID: 33370974
- PMCID: PMC7757443
- DOI: 10.1136/bcr-2020-236971
Lafora body disease: a case of progressive myoclonic epilepsy
Abstract
Progressive myoclonic epilepsy (PME) is a progressive neurological disorder. Unfortunately, until now, no definitive curative treatment exists; however, it is of utmost importance to identify patients with PME. The underlying aetiology can be pinpointed if methodological clinical evaluation is performed, followed by subsequent genetic testing. We report a case of PME that was diagnosed as Lafora body disease. This case emphasises that, suspecting and identifying PME is important so as to start appropriate treatment and reduce the probability of morbidity and prognosticate the family.
Keywords: drugs: CNS (not psychiatric); epilepsy and seizures; memory disorders.
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.BMJ Case Rep. 2010 Nov 5;2010:bcr0120102653. doi: 10.1136/bcr.01.2010.2653. BMJ Case Rep. 2010. PMID: 22791845 Free PMC article.
-
Progressive myoclonus epilepsies: description of a case of Lafora disease with autopsy.Neurologia. 2013 Nov-Dec;28(9):584-6. doi: 10.1016/j.nrl.2012.04.011. Epub 2012 Jun 14. Neurologia. 2013. PMID: 22703635 English, Spanish. No abstract available.
-
[Myoclonic epilepsy of Lafora: a case report].Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(3 Suppl 2):11-6. Zh Nevrol Psikhiatr Im S S Korsakova. 2010. PMID: 20873469 Russian.
-
Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all.Epilepsia. 2008 Dec;49 Suppl 9:13-24. doi: 10.1111/j.1528-1167.2008.01922.x. Epilepsia. 2008. PMID: 19087113 Review.
-
Lafora disease: epidemiology, pathophysiology and management.CNS Drugs. 2010 Jul;24(7):549-61. doi: 10.2165/11319250-000000000-00000. CNS Drugs. 2010. PMID: 20527995 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials